E-LIB Suche - Ergebnisse für: Forconi, F.

1

Activity of venetoclax in patients with relapsed or refract..:

Kater, Arnon P ; Arslan, Önder ; Demirkan, Fatih...
The Lancet Oncology. 25 (2024) 4 - p. 463-473 , 2024

Link: https://doi.org/10.1016/..

2

FOXO1‐RICTOR AXIS INDUCES AKT PHOSPHORYLATION DURING CLL CE..:

Ondrisova, L. ; Seda, V. ; Hoferkova, E....
Hematological Oncology. 41 (2023) S2 - p. 54-56 , 2023

Link: https://doi.org/10.1002/..

3

Robust Bruton's tyrosine kinase (BTK) degradation with NX‐5..:

Linton, K. ; Forconi, F. ; Lewis, D....
Hematological Oncology. 41 (2023) S2 - p. 573-574 , 2023

Link: https://doi.org/10.1002/..

4

Lymph node location and retention properties of DC‐SIGN eng..:

Chiodin, G. ; Tatterton, D. ; Zhang, Y....
Hematological Oncology. 41 (2023) S2 - p. 256-256 , 2023

Link: https://doi.org/10.1002/..

5

Chronic lymphocytic leukemia therapy guided by measurable r..:

Munir, T ; Cairns, D.A ; Bloor, Adrian...
https://eprints.soton.ac.uk/485675/1/23_10063.R2_Proof_hi.pdf. , 2023

Link: https://eprints.soton.ac..

6

Ibrutinib and rituximab versus fludarabine, cyclophosphamid..:

Hillmen, P ; Pitchford, A ; Bloor, A...
https://eprints.whiterose.ac.uk/201645/1/Ibrutinib%20and%20rituximab%20versus%20fludarabine,.pdf. , 2023

Link: https://eprints.whiteros..

7

Ibrutinib and rituximab versus fludarabine, cyclophosphamid..:

Hillmen, P ; Pitchford, A ; Bloor, A...
https://eprints.whiterose.ac.uk/198869/1/PIIS1470204523001444.pdf. , 2023

Link: https://eprints.whiteros..

8

The Serological Sciences Network (SeroNet) for COVID-19: De..:

Karger, Amy B ; Brien, James D ; Christen, Jayne M...
This article is based on a previously available preprint in medRxiv, https://doi.org/10.1101/2022.02.27.22271399. , 2023

Link: https://doi.org/10.1128/..

9

S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS ..:

Hillmen, P. ; Pitchford, A. ; Bloor, A....
HemaSphere. 6 (2022) - p. 46-47 , 2022

Link: https://doi.org/10.1097/..

10

SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold ..:

Binder, Raquel A ; Fujimori, Gavin F ; Forconi, Catherine S...
The Journal of Infectious Diseases. 227 (2022) 3 - p. 371-380 , 2022

Link: https://doi.org/10.1093/..

11

Low Complexity of Infection Is Associated With Molecular Pe..:

Topazian, Hillary M. ; Moser, Kara A. ; Ngasala, Billy...
Frontiers in Epidemiology. 2 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

12

Development of a distributed international patient data reg..:

Andritsos, Leslie A. ; Anghelina, Mirela ; Neal, Jasmine...
Leukemia & Lymphoma. 63 (2022) 13 - p. 3021-3031 , 2022

Link: https://doi.org/10.1080/..

13

P650: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BT..:

Linton, K. ; Collins, G. P. ; El-Sharkawi, D....
HemaSphere. 6 (2022) - p. 548-549 , 2022

Link: https://doi.org/10.1097/..

14

P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACT..:

Owen, R. ; McCarthy, H. ; Rule, S....
HemaSphere. 6 (2022) - p. 1020-1021 , 2022

Link: https://doi.org/10.1097/..

15

P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACT..:

Owen, R ; McCarthy, H ; Rule, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431287/. , 2022

Link: http://www.ncbi.nlm.nih...